Melflufen for Elderly Patients With Relapsed Myeloma
Status:
WITHDRAWN
Trial end date:
2025-03-26
Target enrollment:
Participant gender:
Summary
This is a pilot study aimed to evaluate the efficacy and tolerability of melflufen plus dexamethasone in elderly patients at second relapse.
Thirty elderly patients at second or subsequent relapse.